Ampersand Capital Partners Sells MedVenture Technology to Helix Medical
Private equity firm Ampersand Capital Partners has sold MedVenture Technology Corp. to Helix Medical.
The sale price was not disclosed.
Helix Medical, a division of the Freudenberg Group, is a manufacturer for the medical device and healthcare industries with 10 manufacturing operations worldwide. Medical manufacturing capabilities include design and development, silicone and thermoplastic molding and extrusion, complex catheter systems, assembly, packaging and engineering services.
MedVenture develops and manufactures minimally invasive surgical devices and catheter-based devices for medical device companies.
Ampersand Capital Partners, based in Wellesley, Mass., describes itself as a middle market private equity firm with a focus on growth equity investments in the Healthcare sector.
Amber Walsh is a partner with McGuireWoods LLP focusing on healthcare transactional work and regulatory matters. Her experience includes representation
As a partner with the firm, Geoff has a wide scope of expertise spanning mergers and acquisitions, senior and